Biomarkers Detection & Discovery

Biomarker discovery requires highly assured identification of a biomarker with real-time quantitative information to indicate which proteins are altering to a statistically pertinent degree in response to disease. The discovery of  biomarkers has developed new strategies starting from the initial steps. In the first stage of biomarker discovery proceedings, investigation depends upon mass spectrometry techniques to make unbiased, semiquantitative analysis of changes between healthy and diseased states. The slope of probable  biomarkers generated in the discovery stage is to be further substantiated due to the high false positive rate. It is done through supplemental more targeted and quantitative mass spectrometry techniques, such as immuno affinity peptide enrichment.

Under this track, the latest trends in discovery and development of biomarkers and biomarker identification are discussed. There are many new strategies being fashioned in development of  biomarkers. In this section advancements of biomarkers in various sectors like clinical biomarkers, paediatric diseases biomarkers, and clinical analysis of NGS samples are covered.

  • New strategies for discovery
  • Protein biomarker discovery
  • Clinical biomarker advances
  • Biomarkers for paediatric diseases
  • Clinical analysis of NGS samples
  • Mass spectrometry based biomarker discovery

Related Conference of Biomarkers Detection & Discovery

Biomarkers Detection & Discovery Conference Speakers